We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Full Adherence to HAART: Is It Really Necessary?

Francesca Cainelli, MD; Sandro Vento, MD
Arch Intern Med. 2002;162(8):944-945. doi:.
Text Size: A A A
Published online


In their interesting report, Nieuwkerk and colleagues1 confirm that adherence to highly active antiretroviral therapy (HAART) is limited in patients with human immunodeficiency virus type 1 (HIV-1) infection. The results of their study conducted in the Netherlands are not different from those reported from other countries25 and outline the well-known difficulties in adhering to a complex treatment that requires not only the accurate timing of doses, but also the observance of precise dietary instructions. However, is the patient's full adherence to HAART really vital to avoid disease progression? We believe that the time has come to reconsider the 2 major present "dogmas" in HIV-1 treatment, ie, the necessity of starting therapy using a HAART regimen in all infected subjects, independent of their clinical status, initial viremia, or CD4 cell count, and the importance of doing so to limit the risk of viral resistance due to incomplete suppression of viremia.6

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





April 22, 2002
Pythia T. Nieuwkerk, MA; Joep M. A. Lange, MD, PhD
Arch Intern Med. 2002;162(8):945. doi:.
April 22, 2002
Terry S. Ruhl, MD
Arch Intern Med. 2002;162(8):943-944. doi:.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles